CXCR4 and glioblastoma: also found that VEGF blockade potentiated antitumor efficacy in glioblastoma by reducing TAM recruitment into tumor (79), The combination of VEGFR and CXCR4 inhibitors also showed therapeutic effect in glioblastoma multiforme (GBM) xenografts (80).